medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2005, Number 4

<< Back Next >>

Rev Invest Clin 2005; 57 (4)

Ligase chain reaction testing of pooled urine specimens to diagnose Chlamydia trachomatis infection

Sánchez-Alemán MA, Gutiérrez JP, Bertozzi SM, Frontela-Noda M, Guerrero-Lemus V, Conde-González CJ

Language: Spanish
References: 26
Page: 548-554
PDF size: 72.45 Kb.


ABSTRACT

Objective. The purpose of this study was to assess the utility and validity of pooling urine samples for molecular diagnosis of Chlamydia trachomatis infection. Material and methods. Of 1,220 urine samples collected from Mexican female and male adolescents, 305 pools were composed of fourth individual samples each, based on a calculation of optimal pool size. These were processed by ligase chain reaction (LCR) for the detection of C. trachomatis. Positive and gray-zone pools were reanalyzed individually. Cost savings were calculated comparing actual costs of testing to the cost that would have been incurred testing all 1,220 samples individually. Results. Pools results were: 56 positive, 19 gray-zones and 230 negative. Following individual retesting of positive and gray-zone pools, 59 cases of C. trachomatis infection were identified (4.8% prevalence). Thus, a total of 601 LCR tests were performed, for a 50.4% savings considering only the direct cost of the test. Conclusions. Our experience shows that sample pooling is both a reliable and convenient tool for CT surveillance in our setting. It should be considered in other similar settings where limited resources constraint surveillance of STIs.


REFERENCES

  1. Schachter J. Biology of Chlamydia trachomatis. In: Holmes KK, Sparling PF, Mardh PA, Lemon SM, Stamm WE, Piot P, Wasserheit JN (Eds.). Sexually Transmitted Diseases. 3rd. edition. USA: Mc Graw Hill press; 1999, p. 391-406.

  2. Research on Reproductive Health at WHO: biennial report 2000-2001. Chapter 3: Preventing reproductive tract infection, 31-36. World Health Organization 2002.

  3. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, Goeman J, Behets F, Batter V, Alary M, Heyward WL, Ryder RW, Piot P. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7: 95-102.

  4. Gaydos EA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med 1998; 339: 739-44.

  5. Zelin JM, Robinson AJ, Ridgway GL, Allason-Jones E, Williams P. Chlamydial urethritis in heterosexual men attending a genitourinary medicine clinic: prevalence, symptoms, condom usage and partner change. Int J STD AIDS 1995; 6: 27-30.

  6. Institute of Medicine. The hidden epidemic – confronting sexually transmitted diseases. Washington DC: National Academy Press; 1992, p. 28-68.

  7. Watson EJ, Templeton A, Russell I, Paavonen J, Mardh P, Stary A, Stray Pederson B. The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. J Med Microbiol 2002; 51: 1021-31.

  8. Black CM. Current methods of laboratory diagnosis of Chlamydia trachomatis infections. Clin Microbiol Rev 1997; 10: 160-84.

  9. Black CM, Marrazzo J, Johnson RE, et al. Head-to-Head Multicenter comparison of DNA probe and nucleic acid amplification test for Chlamydia trachomatis infection in women performed with an improved reference standard. J Clin Microbiol 2002; 40: 3757-63.

  10. Center for Disease Control and Prevention. Screening test to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections-2002. MMWR Recommendations and Reports 2002; 51: 1-27.

  11. Krepel J, Patel J, Sproston A, Hopkins F, Jang D, Mahony J, Chernesky M. The impact on accuracy and cost of Ligase Chain Reaction Testing by Pooling Urine Specimens for the Diagnosis of Chlamydia trachomatis infections. Sex Transm Dis 1999; 26: 504-7.

  12. Behets F, Bertozzi S, Kasali M, Kashamuka M, Atikala L, Brown C, Ryder RW, Quinn TC. Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models. AIDS 1990; 4: 737-41.

  13. Kacena KA, Quinn SB, Howell MR, Madico GE, Quinn TC, Gaydos ChA. Pooling Urine Samples for Ligase Chain Reaction Screening for Genital Chlamydia trachomatis Infection in Asymptomatic Women. J Clin Microbiol 1998; 36(2): 481-5.

  14. Lisby G, Scheibel J, Abrahamsson LO, Christensen ES, Paloheimo S. Detection of Chlamydia trachomatis in individual and pooled endocervical and urethral scrapes by a commercial available polymerase chain reaction. APMIS 1994; 102: 797-800.

  15. Morré SA, Meijer CJJLM, Munk C, Krüger-Kjaer S, Winther JF, Jorgensens HO, Van Den Brule AJC. Pooling of urine specimens for detection for Asymptomatic Chlamydia trachomatis Infections by PCR in a Low-Prevalence Population: Cost-Saving Strategy for Epidemiological Studies and Screening Programs. J Clin Microbiol 2000; 38: 1679-80.

  16. Kapala J, Copes D, Sproston A, Patel J, Jang D, Petrich A, Mahony J, Biers K, Chernesky. Pooling Cervical Swabs and Testing by Ligase Chain Reaction are Accurate and Cost-Saving Strategies for Diagnosis of Chlamydia trachomatis. J Clin Microbiol 2000; 38: 2480-3.

  17. Peeling RW, Toye B, Jessamine P, Gemmill I. Pooling of urine specimens for PCR testing: a cost saving strategy for Chlamydia trachomatis control programmes. Sex Transm Infect 2001; 77: 76-7.

  18. Clark AM, Steece R, Crouse K, Campbell J, Zanto S, Kartchner D, Mottice, Pettit D. Multisite Pooling Study Using Ligase Chain Reaction in Screening for Genital Chlamydia trachomatis infections. Sex Transm Dis 2001; 28: 565-8.

  19. Mahony J, Chong S, Jang D, et al. Urine specimens from pregnant and nonpregnant women inhibitory to amplification of Chlamydia trachomatis nucleic acid by PCR, ligase chain reaction, and transcription-mediated amplification: identification of urinary substances associated with inhibition and removal of inhibitory activity. J Clin Microbiol 1998; 36: 3122-6.

  20. Berg ES, Anestad G, Moi H, Storvold G, Skaug K. False-negative results of a ligase chain reaction assay to detect Chlamydia trachomatis due to inhibitor in urine. Eur J Clin Microbiol Infect Dis 1997; 16: 727-31.

  21. Giuliano AR, Denman C, Guernsey de Zapien J, et al. Design and results of the USA-Mexico border human papillomavirus (HPV), cervical dysplasia, and Chlamydia trachomatis study. Rev Panam Salud Pública 2001; 9: 172-81.

  22. Uribe-Salas F, Conde-Glez CJ, Juárez-Figueroa L, et al. Sociodemographic dynamics and sexually transmitted infections in female sex workers at the Mexican-Guatemalan border. Sex Transm Dis 2003; 30: 266-71.

  23. Uribe-Salas F, Hernández-Avila M, Conde-Glez CJ, et al. Low prevalence of HIV infection and Sexually Transmitted Diseases among female commercial sex workers in Mexico City. Am J Pub Health 1997; 87: 1012-15.

  24. Alvarado Esquivel C, Briones Ezcarzaga ML, Castruita Limones DE, et al. Prevalence of Chlamydia trachomatis infection in registered female sex workers in northern Mexico. Sex Transm Dis 2003; 30: 195-8.

  25. Stamm WE. Chlamydia trachomatis infection of the adult. Chapter 29. In Sexually Transmitted Diseases, Holmes KK, Sparling PF, Mardh PA, et al. Editors. Third edition. USA: Mc-Graw Hill; 1999.

  26. Aral SO, Holmes KK. Social and behavioral determinants of the epidemiology of STDs: Industrialized and developing countries, Chapter 4. In Sexually Transmitted Diseases, Holmes KK, Sparling PF, Mardh PA, et al. (Ed.). Third edition. USA: Mc-Graw Hill; 1999.




2020     |     www.medigraphic.com